Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity

Free Radical Biology and Medicine

Volumn 60, Issue , 2013, Pages 264-271

  Miller, Alyson A ^a   Maxwell, Kate F ^a   Chrissobolis, Sophocles ^a   Bullen, Michelle L ^a   Ku, Jacqueline M ^a   Michael De Silva, T ^a   Selemidis, Stavros ^a   Hooker, Elizabeth U ^a   Drummond, Grant R ^a   Sobey, Christopher G ^a   Kemp Harper, Barbara K ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Cerebral vasculature; Free radicals; NADPH oxidase; Nitroxyl; Nox2; Oxidative stress; sGC cGMP

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN II; CYCLIC GMP; CYSTEINE; GUANYLATE CYCLASE INHIBITOR; HYDROGEN PEROXIDE; HYDROXOCOBALAMIN; NITRIC OXIDE; NITROXYL; PHORBOL DIBUTYRATE; POTASSIUM; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASILAR ARTERY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FLUORESCENCE; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; CEREBRAL ARTERIES; HUMANS; HYDRAZINES; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR TARGETED THERAPY; NADPH OXIDASE; NITRIC OXIDE; NITROGEN OXIDES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASCULAR DISEASES;

MUS;

EID: 84875934642     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.02.025     Document Type: Article

References (47)

1. G.R. Drummond, S. Selemidis, K.K. Griendling, and C.G. Sobey Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Nat. Rev. Drug Discovery 10 2011 453 471
2. A.A. Miller, K. Budzyn, and C.G. Sobey Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention Clin. Sci. 119 2010 1 17
3. T.M. De Silva, B.R. Broughton, G.R. Drummond, C.G. Sobey, and A.A. Miller Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species Stroke 40 2009 1091 1097
4. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D.G. Harrison Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J. Exp. Med. 204 2007 2449 2460
5. H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II Arterioscler. Thromb. Vasc. Biol. 27 2007 303 309
6. H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals Arterioscler. Thromb. Vasc. Biol. 26 2006 826 832
7. A.A. Miller, T.M. De Silva, C.P. Judkins, H. Diep, G.R. Drummond, and C.G. Sobey Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia Stroke 41 2010 784 789
8. -/- mice Am. J. Physiol. Heart Circ. Physiol 298 2010 H24 32
9. T.M. De Silva, V.H. Brait, G.R. Drummond, C.G. Sobey, and A.A. Miller. Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke PLoS One 6 2011 e28393
10. A.A. Miller, G.R. Drummond, T.M. De Silva, A.E. Mast, H. Hickey, J.P. Williams, B.R. Broughton, and C.G. Sobey NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2 Am. J. Physiol. Heart Circ. Physiol 296 2009 H220 225
11. A.A. Miller, G.R. Drummond, H.H. Schmidt, and C.G. Sobey NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries Circ. Res. 97 2005 1055 1062
12. J.C. Irvine, R.H. Ritchie, J.L. Favaloro, K.L. Andrews, R.E. Widdop, and B.K. Kemp-Harper. Nitroxyl (HNO): the Cinderella of the nitric oxide story Trends Pharmacol. Sci. 29 2008 601 608
13. M.L. Bullen, A.A. Miller, K.L. Andrews, J.C. Irvine, R.H. Ritchie, C.G. Sobey, and B.K. Kemp-Harper. Nitroxyl (HNO) as a vasoprotective signaling molecule Antioxid. Redox Signaling 14 2011 1675 1686
14. K.L. Andrews, J.C. Irvine, M. Tare, J. Apostolopoulos, J.L. Favaloro, C.R. Triggle, and B.K. Kemp-Harper. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries Br. J. Pharmacol. 157 2009 540 550
15. J.L. Favaloro, and B.K. Kemp-Harper. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature Cardiovasc. Res. 73 2007 587 596
16. - activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries Hypertension 41 2003 1301 1307
17. J.M. Fukuto, K. Chiang, R. Hszieh, P. Wong, and G. Chaudhuri. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor J. Pharmacol. Exp. Ther. 263 1992 546 551
18. M.L. Bullen, A.A. Miller, J. Dharmarajah, G.R. Drummond, C.G. Sobey, and B.K. Kemp-Harper. Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia Am. J. Physiol. Heart Circ. Physiol 301 2011 H1405 1414
19. E. Bermejo, D.A. Saenz, F. Alberto, R.E. Rosenstein, S.E. Bari, and M.A. Lazzari Effect of nitroxyl on human platelets function Thromb. Haemostasis 94 2005 578 584
20. N.D. Tsihlis, J. Murar, M.R. Kapadia, S.S. Ahanchi, C.S. Oustwani, J.E. Saavedra, L.K. Keefer, and M.R. Kibbe. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury J. Vasc. Surg. 51 2010 1248 1259
21. J.M. Fukuto, and S.J. Carrington. HNO signaling mechanisms Antioxid. Redox Signaling 14 2011 1649 1657
22. C.H. Switzer, W. Flores-Santana, D. Mancardi, S. Donzelli, D. Basudhar, L.A. Ridnour, K.M. Miranda, J.M. Fukuto, N. Paolocci, and D.A. Wink. The emergence of nitroxyl (HNO) as a pharmacological agent Biochim. Biophys. Acta 1787 2009 835 840
23. K.M. Miranda, R.W. Nims, D.D. Thomas, M.G. Espey, D. Citrin, M.D. Bartberger, N. Paolocci, J.M. Fukuto, M. Feelisch, and D.A. Wink Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins: a chemical discussion of the differential biological effects of these redox related products of NOS J. Inorg. Biochem. 93 2003 52 60
24. C.H. Leo, A. Joshi, J.L. Hart, and O.L. Woodman Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta Pharmacol. Res. 66 2012 383 391
25. J.C. Irvine, J.L. Favaloro, R.E. Widdop, and B.K. Kemp-Harper Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae Hypertension 49 2007 885 892
26. J.C. Irvine, B.K. Kemp-Harper, and R.E. Widdop Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO Antioxid. Redox Signaling 14 2011 1615 1624
27. B.M. Wynne, H. Labazi, R.C. Tostes, and R.C. Webb Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses Pharmacol. Res. 65 2012 41 47
28. S. Selemidis, G.J. Dusting, H. Peshavariya, B.K. Kemp-Harper, and G.R. Drummond Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells Cardiovasc. Res. 75 2007 349 358
29. J.D. Pollock, D.A. Williams, M.A. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doerschuk, and M.C. Dinauer Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production Nat. Genet. 9 1995 202 209
30. E.C. Chan, S.R. Datla, R. Dilley, H. Hickey, G.R. Drummond, and G.J. Dusting Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits Cardiovasc. Res. 75 2007 710 718
31. A.A. Miller, G.R. Drummond, A.E. Mast, H.H. Schmidt, and C.G. Sobey Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen Stroke 38 2007 2142 2149
32. K.A. Jackman, A.A. Miller, T.M. De Silva, P.J. Crack, G.R. Drummond, and C.G. Sobey Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice Br. J. Pharmacol. 156 2009 680 688
33. F.M. Faraci, K.G. Lamping, M.L. Modrick, M.J. Ryan, C.D. Sigmund, and S.P. Didion Cerebral vascular effects of angiotensin II: new insights from genetic models J. Cereb. Blood Flow Metab. 26 2006 449 455
34. A.A. Miller, G.R. Drummond, and C.G. Sobey Novel isoforms of NADPH-oxidase in cerebral vascular control Pharmacol. Ther. 111 2006 928 948
35. N. Duerrschmidt, C. Stielow, G. Muller, P.J. Pagano, and H. Morawietz NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells J. Physiol. 576 Pt 2 2006 557 567
36. S. Chrissobolis, B. Banfi, C.G. Sobey, and F.M. Faraci Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain J. Appl. Physiol. 113 2012 184 191
37. E.Q. Lin, J.C. Irvine, A.H. Cao, A.E. Alexander, J.E. Love, R. Patel, J.R. McMullen, D.M. Kaye, B.K. Kemp-Harper, and R.H. Ritchie. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation PLoS One 7 2012 e34892
38. J.M. Vincent, Y.W. Kwan, S.L. Chan, C. Perrin-Sarrado, J. Atkinson, and J.M. Chillon Constrictor and dilator effects of angiotensin II on cerebral arterioles Stroke 36 2005 2691 2695
39. K.A. Jackman, A.A. Miller, G.R. Drummond, and C.G. Sobey Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke Brain Res. 1286 2009 215 220
40. R.L. Haberl, F. Anneser, A. Villringer, and K.M. Einhaupl. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles Am. J. Physiol. 258 6 Pt 2 1990 H1840 1846
41. C. Capone, G. Faraco, J. Anrather, P. Zhou, and C. Iadecola Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II Hypertension 55 2010 911 917
42. 2+ cycling Circ. Res. 100 2007 96 104
43. T. Dai, Y. Tian, C.G. Tocchetti, T. Katori, A.M. Murphy, D.A. Kass, N. Paolocci, and W.D. Gao. Nitroxyl increases force development in rat cardiac muscle J. Physiol. 580 Pt 3 2007 951 960
44. C.G. Tocchetti, B.A. Stanley, C.I. Murray, V. Sivakumaran, S. Donzelli, D. Mancardi, P. Pagliaro, W.D. Gao, J. van Eyk, D.A. Kass, D.A. Wink, and N. Paolocci Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function Antioxid. Redox Signaling 14 2011 1687 1698
45. W. Flores-Santana, D.J. Salmon, S. Donzelli, C.H. Switzer, D. Basudhar, L. Ridnour, R. Cheng, S.A. Glynn, N. Paolocci, J.M. Fukuto, K.M. Miranda, and D.A. Wink. The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems Antioxid. Redox Signaling 14 2011 1659 1674
46. S. Lancel, J. Zhang, A. Evangelista, M.P. Trucillo, X. Tong, D.A. Siwik, R.A. Cohen, and W.S. Colucci Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674 Circ. Res. 104 2009 720 723
47. B.M. Babior The leukocyte NADPH oxidase Isr. Med. Assoc. J. 4 2002 1023 1024